Trials / Recruiting
RecruitingNCT04664946
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT)
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT): One Single Center, Safety and Feasibility Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Hui-Sheng Chen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To explore the safety and feasibility of intra-arterial neuroprotective strategy in acute ischemic stroke patients who missed recanalization operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intra-arterial administration of neuroprotective agents | Intra-arterial administration of 3-n-butylphthalide for 24 hours via microcatheter at 17.36 ug/min. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2020-12-11
- Last updated
- 2025-08-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04664946. Inclusion in this directory is not an endorsement.